Boule Diagnostics Investor Relations Material
Latest events
Q2 2025
Boule Diagnostics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Boule Diagnostics
Access all reports
Boule Diagnostics designs and manufactures instruments and consumables for use in laboratories around the globe to provide fast, accurate blood diagnostics. The company develops new technology platforms that offer improved speed, performance and reliability, broaden range and applicability of tests, and increase automation workflow efficiency through more effective diagnostics.
Key slides for Boule Diagnostics
Q4 2024
Boule Diagnostics
Q1 2025
Boule Diagnostics
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
BOUL
Country
🇸🇪 Sweden